We focus on public healthcare companies whose products and services have the potential to expand access, improve outcomes, and lower the cost of care. Our process combines fundamental company research, evaluation of clinical and commercial trajectories, and an understanding of how healthcare solutions are adopted, reimbursed, and scaled.

Alongside this fundamental work, we apply a proprietary quantitative framework that ranks companies across measures of value, quality, and growth. The framework helps us identify candidates worth deeper diligence and provides a disciplined check on positioning decisions across the portfolio.

We take a long-term view, believing that the most meaningful value creation comes from compounding business performance over years, not quarters.